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Abstract
Background & Aims—SAMP1/Yit mice develop spontaneous, segmental, transmural ileitis
recapitulating many features of Crohn’s disease (CD). The ileitic phenotype may have arisen
during crosses of SAMP1 mice selected for the presence of skin lesions. We hereby describe that
the original SAMP1 strain similarly develops ileitis. Our aim was to characterize the
histopathological and immunological features of this model and assess its responsiveness to
standard IBD therapy.
Methods—The time course of histopathological features of ileitis was assessed. Immune
compartments were characterized by flow cytometry. Ileal cytokine profiles and transcription
factors were determined by real-time RT-PCR. Finally, response to corticosteroid therapy and its
effect on immune compartments and cellularity was evaluated.
Results—Histological features and time course of disease were conserved, compared to those
reported in SAMP1/Yit strains, with similar expansion of CD19+, CD4+ and CD8+ effector
(CD44highCD62Llow), and central memory lymphocytes (CD44highCD62Lhigh). However,
different from SAMP1/YitFc mice, analysis of ileal cytokine profiles revealed initial TH1
polarization followed by TH2-polarized profile accompanied by prominent eosinophilia during
late disease. Lastly, corticosteroids attenuated ileitis resulting in decreased lymphocyte subsets and
cellularity of compartments.
Conclusions—Here we report that the ileitic phenotype of SAMP1-related strains was already
present in the original SAMP1 strain. By contrast the cytokine profile within terminal ilea of
SAMP1 is distinct from the mixed TH1/TH2 profile of SAMP1/YitFc mice during late disease, as
it shows predominant TH2 polarization. Dissemination of these strains may advance our
understanding of CD pathogenesis, which in 60% of patients involves the terminal ileum.
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Introduction
In 1932 Crohn and colleagues described a chronic disease of young adults involving the
terminal ileum (1). Almost 80 years later we still lack an explanation for this particular
localization, but it is likely that the relationships between the heavy bacterial load (109 CFU)
and immune-rich environment of the terminal ileum are key contributors. The inflammatory
process described by Crohn was segmental, transmural and accompanied by marked
thickening of the muscularis propria. Inflammation within that segment was then attributed
to M. tuberculosis, yet no infectious etiology could be identified(1).
Since then, many animal models of inflammatory bowel disease (IBD) have been described
(2–4). Yet most IBD models affect the large intestine rather than the small bowel, are
generated by chemical, immunologic or genetic manipulation and are self-limited in nature.
Although these colitic models have greatly expanded our understanding of the pathogenesis
of the disease, few really recapitulate the features of the inflammatory process described by
Crohn (transmural, segmental chronic inflammation). Furthermore, even fewer exhibit
chronic inflammation localized to the terminal ileum, as was present in all original cases
described by Crohn(1).
This changed eleven years ago when Matsumoto described a senescence-accelerated mouse
(SAM)P1/Yit strain which developed spontaneous ileitis, while loosing its accelerated
senescence phenotype(5). The SAMP1/Yit strain was generated by crossing SAMP1 mice,
selected for the presence of skin lesions. SAMP1 mice were obtained from Dr. Toshi
Takeda, who developed the strain from AKR/J mice while studying the genetics of aging(6).
Since Matsumoto’s original description, it was believed that the ileitic phenotype appeared
during these crosses. To ascertain whether this was the case, we obtained the original
SAMP1 mice from Dr. Takeda and evaluated their terminal ilea for the presence of ileitis.
Unexpectedly, the SAMP1 strain, like its derivative substrains (i.e. SAMP1/Yit, SAMP1/
YitFc, SAMP1/YP), also develop terminal ileitis, phenotypically indistinguishable from that
of other SAMP1/Yit strains. The selection of mice with skin lesions did not appear to have
contributed to the appearance of the ileitic phenotype, as has been previously believed(7).
In the present study, we performed a longitudinal study of the histological and inflammatory
characteristics of ileitis in SAMP1 mice. Unexpectedly, different from the mixed TH1/TH2
ileal cytokine profile observed during advanced disease in SAMP1/Yit mice, SAMP1 mice
exhibited prominent TH2 polarization after 20-weeks-of-age. Due to the increases in IL-5
and IL-13 transcripts within their chronically inflamed ilea, we assessed for eosinophilic
infiltration by immunohistochemistry. Finally, we assessed whether the ileitis of SAMP1
mice responds to corticosteroid therapy.
Materials & Methods
Mice
SAMP1 (SAMP1/SkuSlc) female mice 4- to 20-weeks-of-age were purchased from Japan
SLC, Inc. (Hamamatsu, Japan). AKR mice (AKR/J; a/a Tyrc/Tyrc Soat1ald/Soat1ald hid/hid),
from which SAMP strains were derived were purchased from the Jackson Laboratory (Bar
Harbor, ME) to serve as controls. All animals were maintained under micro-isolator
conditions. Food and water were available ad libitum. Fecal samples were negative for
Helicobacter hepaticus and bilis and other murine Helicobacter species, and for protozoa and
helminths. All animal procedures were approved by the Institutional Committee for Animal
Use of the University of Colorado, Denver.
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Tissue Collection and histological analyses
The distal ilea (10 cm) were fixed in 10% buffered formalin, paraffin-embedded, cut into 5
μm sections and stained with hematoxylin/eosin. Histological assessment of ileal
inflammation was performed using a standardized semi-quantitative scoring system, as
described(8). Briefly, scores were given for 3 histologic parameters: (1) active inflammation
(granulocyte infiltration); (2) chronic inflammation (lymphocytes, plasma cells, and
macrophages in the mucosa and submucosa); and (3) villus distortion (flattening and/or
widening of normal villous architecture). Scoring was performed by a pathologist (PJ),
blinded to the time point, strain and treatment groups.
Lymphocyte Isolation
Single-cell suspensions were obtained by passing the spleen or MLN through a 100μm cell-
strainer. Red blood cells were lysed by 5 minute incubation in lysing reagent (BD PharM
Lyse, BD Biosciences, San José, CA). The cell suspension was pelleted by centrifugation
and re-suspended in complete medium (RPMI 1640 with 10% fetal bovine serum, 2 mmol/L
L-glutamine, and 1% penicillin/streptomycin).
Flow Cytometry
Cells from indicated compartments were incubated with fluorescently-labeled antibodies
against: mouse CD4 (GK1.5), CD19 (1D3), L-selectin (MEL-14) (BD Biosciences, San
José, CA), CD8α (53–6.7), CD8β (Ly-3), CD44 (IM7) (Biolegend, San Diego, CA), TCRβ
(H57-597), (BD Pharmingen) or corresponding isotype controls. Cells were fixed with 2%
paraformaldehyde and 7-color analyses were performed using the BD FACSCanto™ II (BD
Biosciences, San Jose, CA). Further analyses were performed using FLOWJo software (Tree
Star Inc, Ashland, OR).
Real-Time RT-PCR
Total RNA was isolated from homogenized ilea using the RNeasy Mini Kit (QIAGEN,
Valencia, CA). RNA samples (1μg) were reverse transcribed into cDNA with a high
capacity cDNA archive kit (Applied Biosystems, Foster City, CA) and Real-time PCR
performed using an ABI Prism 7300 instrument. Taqman Gene Expression Assays (Applied
Biosystems, Foster City, CA) containing primers and a FAM™ dye-labeled TaqMan® MGB
probes were used to quantify genes of interest. Assay designations were as follows: IL-5
(Mm99999063_m1), IL-13 (Mm00434206_g1), TNF (Mm00443258_m1), IFN-γ
(Mm00801778_m1), GATA3 (Mm01337569_m1) and T-bet (Mm00450960_m1). PCR was
performed in a 20μl reaction volume (9μl of diluted cDNA, 1μl of Taqman gene expression
assay and 10μl of Taqman® Universal PCR Master Mix). PCR was performed in duplicate,
using universal cycling conditions per manufacturer’s instructions (Applied Biosystems,
Foster City, CA). Thermocycling conditions were: 95°C for 10 minutes, 40 cycles of 95°C
for 15 seconds, and 60°C for 1 minute. 18S was used as endogenous control to normalize
gene expression data, and an RQ value (2−DDCt, where Ct is the threshold cycle) was
calculated for each sample using ABI RQ software (Applied Biosystems, Foster City, CA).
RQ values are presented as fold change in gene expression relative to the control group.
Major basic protein (MBP) immunostaining
MBP immunostaining was performed as previously described(9). Briefly, 5-μm sections
were quenched with H2O2, blocked with normal goat serum, and stained with rabbit anti-
murine eosinophil MBP antisera. Slides were washed and incubated with biotinylated goat
anti-rabbit antibody and avidin-peroxidase complex (Vectastain ABC Peroxidase Elite kit;
Vector Laboratories, Burlingame, CA), developed by nickel diaminobenzidine, enhanced
with cobalt chloride and counterstained with methyl green. Quantification of
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immunoreactive cells was performed using NIS-Elements Imaging Software (Nikon
Microscopes, Melville, NY). Seven images were acquired and assessed from randomly
selected locations of each ileal section (n=5/strain and age/group). Eosinophils wre
quantified using the standard area measurement (S.A.M.) technique. Briefly, the area
occupied by an eosinophil was assessed and the S.A.M determined for a single eosinophil.
The total MBP-positive area was determined for each field and divided by the S.A.M. to
obtain the number of eosinophils per high power field.
Corticosteroid treatment
11-week-old SAMP1 mice received 4 intraperitoneal (I.P.) injections of 100μg
dexamethasone (VEDCO, St. Joseph, MO) or saline vehicle every other day for 8 days.
Tissue was harvested 24 hours after the last injection.
Statistical Analysis
Statistical analyses were performed using the two-tailed Student’s t-test. Data were
expressed as mean ± standard error of the mean (SEM). Statistical significance was set at P
< 0.05.
Results
Histological progression of SAMP1 ileitis
Ileal inflammation was not observed in SAMP1 or AKR mice at 5-weeks-of-age. Histologic
examination of the esophagus, stomach, duodenum, jejunum, cecum and colon revealed no
inflammation (not shown). However, by 10-weeks-of-age, SAMP1 mice displayed
significant ileitis (Figure 1A, B). All indices increased (villus distortion, active, chronic,
total) compared to AKR (mean ± S.E.M. from 5-to 50-weeks-of-age) and 5-week-old
SAMP1 (villus distortion: 3.2 ± 0.6, P< .001; active: 2.5 ± 0.5, P=.002; chronic: 3.6 ± 0.9,
P=.006; total: 9.6 ± 2, P<.002) (Figure 1A). Between 10- and 50-weeks-of-age there was
progression of the severity of villus distortion and active inflammation reaching a maximum
of 6.2 ± 0.8 and 6.3 ± 0.7 respectively. Histological hallmarks of disease included
transmural, mixed inflammatory infiltrates from the mucosa to the serosa. Chronically-
inflamed 20-week-old and older mice additionally exhibited crypt elongation, lymphoid
aggregates, rare giant cells and further progression of transmural infiltrates, accompanied by
blunting of the villi, crypt and goblet cell hyperplasia (Figure 1B)
Expanded lymphoid compartments in SAMP1 mice
At 5-weeks-of-age, while no histological evidence of ileitis was identified, significant
expansion of splenic cellularity was observed (Figure 2A & B). By 20-weeks-of-age, there
was further expansion in the cellularity of the MLN and spleen (Figure 2A). Further
compartment flow cytometric analysis revealed increased absolute numbers of CD4+, CD8+
and CD19+ lymphocytes compared to AKR controls at 20-weeks-of-age in both MLN and
spleen (Figure 2C & D). As observed in the SAMP1/Yit mice, a large increase in the
numbers CD4+ and CD8+ αβ+ lymphocyte subpopulations was observed, compared to AKR
controls(10) (Table 1).
Increased effector and central memory T lymphocytes correspond with severity of SAMP1
ileitis
Further characterization of 5-week-old AKR and SAMP1 splenocytes revealed significant
differences in both TEM and TCM within the CD8+ subset (P=.02, P=.03 respectively) and
for TEM within the CD4+ population (CD4+ P<.0001). Analysis of the SAMP1 MLN at 5-
weeks-of-age displayed significant expansion of TCM compared to AKR mice (P<.0001).
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While there was no significant increase in SAMP1 CD4+ TEM within the MLN by 20-
weeks-of-age (Figure 3, upper panel), all other populations in MLN and spleen were
markedly increased, corresponding with worsening disease (AKR vs. SAMP1; P<.05; Figure
3, lower panels).
Early and late disease are characterized by distinct TH1 and TH2 cytokines profiles in the
SAMP1 ileum
Cytokine profiles of the SAMP1 ileum revealed TH1 polarization with significant fold
increases in the expression of IFN-γ and TNF mRNA at 5 and 10 weeks. Conversely, a
distinct TH2 expression profile characterized late disease (>20-weeks-of-age) as both TNF
and IFN-γ decreased to basal levels, while the levels of IL-5, IL-13 and IL-10 were
significantly up-regulated (Figure 4).
Expression of transcription factors Tbet and GATA3 correspond to cytokine profiles in
early and late ileitis
The expression of transcription factors which orchestrate TH1 and TH2 cell polarization,
Tbet and GATA3, were assessed in ilea. Greater expression of Tbet predominated during
early disease in SAMP1 mice (5 weeks; Tbet 0.75 ± 0.2 vs. 2.5 ± 0.5, P<.005; GATA3, 0.6
± 0.1 vs. 1.62 ± 0.2, P=.002). Consistent with the pronounced expression of IL-5, IL-13 and
IL-10 during chronic disease, the ratio of GATA3 expression was significantly elevated
compared to Tbet in SAMP1 ileum by 50-weeks-of-age (GATA3/Tbet ratio: 50 weeks 1.34
± 0.21 vs. 5.9 ± 1.1, P< .007) (Figure 5).
Increased eosinophilic infiltrates distinguish late ileitis in SAMP1 mice
To further define the TH2 inflammatory milieu, we performed additional cellular
characterization of ilea of AKR and SAMP1 mice. As eosinophilic infiltration is difficult to
assess with traditional staining methods, we utilized immunohistochemical staining with
anti-major basic protein (MBP) antibody. Quantification of eosinophils of SAMP1 ileal
tissue revealed a marked increase in eosinophil numbers by 20-weeks-of-age, compared to
AKR mice (5 week SAMP1 vs. 20 week SAMP1: 2.6 ± 0.4 vs. 51 ± 10, P=.004) (Figure 6A)
coinciding with increased IL-5 and IL-13 expression (Figure 4). Representative MBP-
stained tissue sections from 20-week-old SAMP1 displayed prominent ileal eosinophilic
infiltrates from the muscularis to the villus tips (Figure 6B).
Therapeutic treatment with corticosteroids
As corticosteroids are clinically proven to treat flares of CD, we assessed the effects of
dexamethasone (Dex) on the severity of SAMP1 ileitis. Treatment of 11-week-old SAMP1
mice led to marked attenuation of ileitis, as evidenced by significant reduction in MLN and
spleen cellularity and inflammatory indices (Vehicle vs. Dex: Active: 1.2 ± 0.2 vs. 0.14 ±
0.1, P=0.003, chronic: 1.4 ± 0.2 vs. 0.05 ± 0.03, P=.002, total: 4.8 ± 0.5 vs. 0.5 ± 0.3, P=.
002). Dexamethasone treatment also significantly restored villus architecture (vehicle vs.
Dex: 1.6 ± 0.4 vs. 0.1 ± 0.1, P=.004) (Figure 7A). In addition, other histological hallmarks
of disease: muscularis propria, goblet and paneth cell hyperplasia, were diminished (Figure
7B). Marked reduction in lymphocyte counts in MLN (vehicle vs. Dex: 90.7 ± 6.8 vs. 30 ±
0.4, P=.004) and spleen (161.7 ± 4.2 vs. 53.2 ± 5.4, P<.0001) were observed.
Dexamethasone treatment decreased IFN-γ (vehicle vs. Dex: x 4.9 ± 1.4 vs. x 0.8 ± 0.2, P=.
002) and TNF (vehicle vs. Dex: x 2.9 ± 0.9 vs. x 0.8 ± 0.1, P<.002) mRNA levels in SAMP1
ilea, which were comparable to that of uninflamed AKR controls. Taken together these
results demonstrate that SAMP1 ileitis responds to standard therapy used in CD.
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Discussion
Eleven years after the description of the first mouse model of spontaneous, segmental,
transmural Crohn’s-like ileitis (i.e. SAMP1/Yit)(5), access to this unique resource has been
limited. In the present report we characterize a novel commercially available SAMP strain
(SAMP1) that, like its related strains, (i.e. SAMP1/Yit(5), SAMP1/YitFc(10), and SAMP1/
YP(11)) develops spontaneous segmental, transmural ileitis with 100% penetrance. Similar
to the SAMP1/YitFc strain, mice develop near maximal disease by 10-weeks-of-age with
increased size and cellularity of lymphoid compartments and expansion of effector and
central memory T cell subsets. By contrast the cytokine profile within the inflamed terminal
ilea of SAMP1 is distinct from the mixed TH1/TH2 profile of SAMP1/YitFc mice during
late disease, as it shows a predominant TH2 polarization(12). Furthermore, SAMP1 ileitis
responds dramatically to corticosteroids, with near resolution of ileitis and marked reduction
of the cellularity of lymphoid compartments.
Few animal models develop spontaneous IBD (e.g. Cotton Top Tamarins(13), C3H/
HejBir(14) and SAMP1 strains(5)). The original SAMP strains were developed by Dr.
Toshio Takeda after over 24 brother-sister matings of AKR mice obtained from The Jackson
Laboratory (Bar Harbor, Maine, USA)(6). The authors reported alopecia, loss of activity and
shortened life span, among other phenotypic features(5). Sub-strains of these mice were
termed “senescence accelerated mouse”, and later, (SAM)P to denote “senescence-prone”
variants. Five separate series of the strain were further divided into SAMP-1, -2, -3, -4 and
-5(6). The SAMP1/Yit model of ileitis, described by Matsumoto and colleagues, was
developed by continuous brother-sister mating of SAMP1 mice displaying skin lesions,
which correlated with the presence of intestinal inflammation(5). Although the precise cause
of ileitis in these mice is still unknown, it is likely that as in CD, genetic and environmental
factors (such as the bacterial flora), play an important role.
While ileitis in Japanese SAMP1/Yit mice was not evident until 20-weeks-of-age, SAMP1
mice develop robust ileitis by 10-weeks-of-age. This earlier onset of disease may point
towards differences in the microbiota, although the true cause of their divergent phenotypes
is unclear at the present time. Prior studies in the Fc substrain showed an inverse correlation
between the presence of skin lesions and the severity of ileitis(15). We speculate that the
strategy followed by Matsumoto and colleagues to breed mice with skin lesions might have
resulted in delayed disease onset (~30 weeks). We show that the time course of ileitis in
SAMP1, (from which the Yit strain was derived) is closer to the Fc substrain, where mice
with skin lesions were not selected as breeders(10, 15). The early induction of TNF and
IFN-γ mRNA transcripts in the ileum and the modest splenomegaly by 5-weeks-of-age in
SAMP1 mice additionally point towards accelerated disease, compared to the SAMP1/Yit
strain(5). By 10-weeks-of-age, the SAMP1 mice display transmural mixed inflammatory
infiltrates and segmental hypertrophy of the muscularis propria. As disease progresses to 20-
weeks-of-age, increased transmural infiltrates and villous distortion were evident. Crypt
elongation and prominent goblet cell hyperplasia were also prominent pathological features.
This exacerbated disease pathology also correlates with prominent expansion in cellularity
of the draining mesenteric lymph node, and peripherally in the spleen, reflecting a systemic
dysregulated immune response.
As reported in the SAMP1/Yit mice, we observed expansion of CD4+, CD8+ and CD19+
lymphocyte populations in the SAMP1 strain(10, 16). Characterization of the lymphocyte
populations revealed increased αβ+ T-cell receptor subsets. As described by Kosiewicz and
colleagues, CD4+ lymphocytes from SAMP1/Yit mice displayed an activated phenotype
with increased fractions of CD25+, CD69+ and CD44+(10). Here we report that SAMP1
mice similarly exhibited prominent expansion of CD44highCD62Llow effector TEM and
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CD44highCD62Lhigh central memory TCM phenotypes. This expansion appears to correlate
with disease severity, as is evident by 20-weeks-of-age. As central memory TCM
lymphocytes express L-selectin (CD62L), they likely play a role in secondary responses and
long-term memory by recirculating to secondary lymphoid organs and contributing to the
perpetuation of the disease(17, 18). Conversely, effector memory TEM lymphocytes, which
lack L-selectin, home to effector sites (e.g. the terminal ileum) and contribute to
inflammatory responses through their production of cytokines (i.e. IFN-γ, TNF)(17). Modest
expansion of CD4+ and CD8+ CD44high TEM cells in the MLN and spleen, along with the
early induction of IFN-γ and TNF suggest that at the biochemical level, the disease is
already present by 5-weeks-of-age and further supports a pathogenic role of effector T-cells
in the induction of ileitis in SAMP1 mice.
There appears to be a strict polarization between TH1 and TH2 cytokine phenotypes in many
animal models of inflammatory bowel disease(3, 19). Prior studies have shown that the
SAMP1/Yit model of ileitis shares similar pathogenic mechanisms with human CD, with
predominant TH1 cytokine profile and CD4+ T-cells mediating early disease progression(3,
10). Furthermore, attenuation of SAMP1/Yit ileitis was reported by immunoneutralization of
TNF and IFN-γ(12, 20). Analysis of the late ileitis in SAMP1/Yit mice revealed a role for
both TH1 and TH2 cytokines during advanced disease and unexpectedly anti-IL-4 therapy
ameliorated disease severity, by decreasing IFN-γ expression(12). These results highlight
the synergistic balance between TH1 and TH2 cytokines during chronic mucosal
inflammation and the complexity and interplay of cytokine biology in chronic models of
IBD. Of note is that analysis of SAMP1/Yit cytokine expression along the time course of
ileitis displayed a continuous increase of TNF and IFN-γ expression, emphasizing their role
in disease progression(12, 15). Unlike the SAMP1/Yit strain, the ileitis observed in the
SAMP1 mice appears to be strictly TH1-polarized during disease onset, whereas TH2
cytokines were predominantly expressed during late disease. Thus, despite remarkably
similar histopathologic features, the SAMP/Yit, the SAMP1/YitFc and the SAMP1 are not
identical, with each strain presenting unique phenotypic characteristics.
A general consensus is that TH1 cytokines critically contribute to the pathogenesis of CD.
TH1 responses display prominent transmural infiltration that in some cases are associated
with granulomata(19). Conversely, TH2 mediated inflammation is characterized by a greater
polymorphonuclear infiltrate and disrupted epithelial cell layer(3). This diversity in disease
phenotype is evidenced by the high levels of TNF, IFN-γ and IL-12 in areas of active
CD(21, 22) and further supported clinically by the nearly 70% therapeutic efficacy of TNF
inhibitors (e.g. infliximab)(23). By contrast, TH2 cytokines are believed to play a major role
in ulcerative colitis(2, 19, 24). However the clinical experience suggests that this might be a
simplistic view, as evidenced by the efficacy of TNF inhibitors in 50% of patients with
UC(25). A critical point is that TH1-mediated inflammation may switch to TH2
inflammation in chronic models of IBD. This has been shown in IL-10-deficient mice,
where IL-4-induced GATA-3 suppression of IL-12 signaling gradually accumulates, and
ultimately a TH2 cytokine profile predominates(3, 26).
Of interest is the marked eosinophilic infiltration of the lamina propria in SAMP1 ileum
during late disease. This observation appears to correlate with the sustained induction of
IL-5 and IL-13. Increased eosinophilia and IL-5 expression have been previously reported in
CD(27, 28) and both may play a role in inflammatory as well as allergic disease(29, 30). The
function of IL-13 in chronic human disease is currently controversial although an increased
correlation between IL-13 and ulcerative colitis has been reported(31, 32). Conversely,
Inoue and colleagues report suppression of IL-13 in UC and an increase in CD (26, 33) (34).
While a variety of mechanisms may be responsible, increased IL-13 production in late
disease may reflect decreased negative feedback by IFN-γ (34).
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In conclusion, our results strongly suggest that Crohn’s disease and the chronic ileitis of
SAMP1 ileitis share similar pathogenic mechanisms of disease. As in Crohn’s disease, TH1
effector and effector memory T-cells appear to be involved in early SAMP1 ileitis, likely
due to systemic immune dysregulation. Large numbers of activated T cells infiltrate the
intestine and draining lymphoid tissues of SAMP1 mice and patients with CD and correlate
with disease severity. The hereby described distinct TH1 and TH2 cytokine profiles between
SAMP1/Yit, SAMP1/YitFc and SAMP1 are not surprising, as these strains have been bred
in isolation for over 20 years. Thus the SAMP1 mice represent an additional tool to
understand critical aspects of the pathogenesis of IBD. Its dissemination to the general
scientific community may greatly advance our understanding of many important aspects of
CD pathogenesis.
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Figure 1. Time course and histological features of ileitis in SAMP1 mice
Inflammatory indices (Villus distortion, active, chronic and total) were assessed by a
pathologist (PJ) in a blinded fashion using a previously described scoring system, from 5- to
50-weeks-of-age. Normal villus, crypt and muscularis architecture was evident at 5-weeks-
of-age. At 10-weeks-of age, transmural mixed inflammatory infiltrates; goblet and crypt
hyperplasia and hypertrophy of the muscularis propria were present. Further progression of
transmural infiltrates, villus distortion and muscularis hypertrophy were observed in 20- to
50-week-old mice with additional crypt elongation and prominent goblet cell hyperplasia.
Scale bars represent 100μm. Data expressed as mean ± SEM, **P<.01 vs. total mean ± SEM
for age-matched AKR controls from 5- to 50-weeks-of-age (n=5–9/age group).
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Figure 2. Expansion of lymphoid compartments and lymphocyte subsets in SAMP1 mice
(A & B) Lymphoid compartments (MLN and spleen) of SAMP1 mice displayed increased
size and cellularity compared to uninflamed AKR controls. (B) Representative pictures
show SAMP1 MLN and spleen of indicated strains at 20-weeks-of-age. (C & D) Flow
cytometric analyses revealed expansion of indicated lymphocyte subsets. (A.) Data
expressed as mean ± SEM, *P<.05, **P<.01, ***P<.001 (C & D) vs. 20-weeks-of-age AKR
control (n=6/strain).
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Figure 3. Expansion of effector (TEM) and central memory T-lymphocytes (TCM) in SAMP1
mice
Flow cytometric analyses of SAMP1 and AKR mice MLN and spleen displayed expansion
of effector TEM (CD44highCD62Llow) and central memory (CD44highCD62Lhigh) TCM
CD4+ and CD8+ T-lymphocytes. Representative zebra plots gated on forward and side
scatter, CD4+ and CD8+ were obtained from cells isolated from indicated organs at 5- and
20-weeks-of-age (n=4–6/strain).
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Figure 4. Differential ileal cytokine expression profiles during early and late SAMP1 ileitis
Relative mRNA expression of indicated cytokines along the time course of the disease were
evaluated in ilea of AKR and SAMP1 mice. Increased TNF, IFN-γ and IL-10 transcripts
were observed at 5- to10-weeks-of age while IL-5, IL-13 expression peaked at 20-weeks-of-
age and remain elevated thereafter. Target cytokines were normalized to 18S ribosomal
RNA. Data expressed as means ± SEM, *P<.05, **P<.01 vs. Age-matched AKR control
(n=5–6/strain).
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Figure 5. Differential ileal cytokine transcription factor expression profiles during early and late
SAMP1 ileitis
Tbet (TH1) and GATA3 (TH2) relative mRNA expression was assessed during early and late
disease. GATA3/Tbet ratio represents the GATA3 and Tbet mRNA ratio of SAMP1
compared to uninflamed AKR control mice at 5- and 50-weeks-of-age. Target transcription
factors were normalized to 18S ribosomal RNA. Data expressed as means ± SEM, *P<.05,
**P<.01 vs. age-matched AKR control (n=5–6/strain).
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Figure 6. Increased eosinophilic infiltration of the chronically inflamed SAMP1 ileum
(A) Eosinophilic infiltration of the ileal lamina propria was assessed by immunostaining for
MBP during early and late ileitis in SAMP1 mice and AKR mice (n=5). Data expressed as
means ± SEM, ***P<.001 vs. 5-week-old SAMP1. (B) Representative MBP
immunostaining of indicated strains at 20-weeks-of-age, scale bars represent 100μm.
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Figure 7. Corticosteroid therapy attenuated ileitis, decreased lymphoid organ cellularity and
TH1 cytokine transcripts in ilea of SAMP1 mice
(A & B) Dexamethasone administration (100μg, I.P., Q.O.D. over 8 days) attenuated disease
indices and restored intestinal architecture in 11-week-old SAMP1 mice compared to age-
matched saline-treated (vehicle) controls. (C) The cellularity of the MLN and spleen as well
as (D) IFN-γ and TNF ileal mRNA expression were additionally decreased. Target cytokines
were normalized to 18S ribosomal RNA. Data expressed as means ± SEM, *P<0.05, **P<.
01, ***P<.001 vs. age-matched AKR control, ++P<.01 vs. Vehicle treated SAMP1. Scale
bars represent 100μm (A & C; n=6–7, D; n=3)
McNamee et al. Page 17
Inflamm Bowel Dis. Author manuscript; available in PMC 2013 September 30.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
McNamee et al. Page 18
Table 1
Expansion of αβ+ and γδ+ T-cell subsets in the MLN and spleen of SAMP1 mice
Absolute counts calculated by correcting the cellularity of the lymphoid compartments by the percentage of
cells expressing indicated T cell receptors at 20-weeks-of-age.
MLN
Phenotype AKR SAMP1/SkuSIc P value
CD4αβ+ 7.8 ± 0.6 26.5±1.3 P<0.0001
CD8αβ+ 1.0 ± 0.2 5.4 ± 1.0 P=0.007
Spleen
Phenotype AKR SAMP1/SkuSIc P value
CD4αβ+ 8.0 ± 1.7 25 ± 2.0 P=0.005
CD8αβ+ 1.5 ± 2.0 11 ±1.0 P=0.001
Data expressed as mean percentage cellularity ± SEM, (student t-test; n=6)
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